David Greenwald, PhD

Dave serves on the Board of Managers of Apertura Gene Therapy.

Dr. Greenwald was a Howard Hughes Medical Institute research fellow while earning a B.S. in Cellular Biology and Molecular Genetics from the University of Maryland, College Park and earned his PhD in Genetics from Tufts University. Dr. Greenwald currently serves on the Boards of Jaguar Gene Therapy, Axovia Therapeutics, and Apertura Gene Therapy, and has worked at Deerfield Management since 2018.